Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol/Fluticasone Inhalation Powder in Adult Asthma
CTR20221128Phase 3Completed
- Sponsor
- Joincare Pharmaceutical
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salmeterol + fluticasone in asthma, sponsored by Joincare Pharmaceutical. Started Jun 2022; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20221128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221128.